CASC

Cascadian Therapeutics, Inc.
CASC

Overview Fund Activity
Delisted

CASC was delisted on the 8th of March, 2018.

Back to rankings

86 hedge funds and large institutions have $98.3M invested in Cascadian Therapeutics, Inc. in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 16 closing their positions.

Holders
86
Holders Change
–
Holders Change %
0%
% of All Funds
2.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
33
Reduced
20
Closed
16
Calls
$972K
Puts
$158K
Net Calls
+$814K
Net Calls Change
-$605K

Top Buyers

1
GPP
1
Great Point Partners
Connecticut
$7.5M
2
DM
2
Deerfield Management
New York
$4.33M
3
BC
3
Broadfin Capital
New York
$2.88M
4
HCMT
4
Highland Capital Management (Texas)
Texas
$2.41M
5
QF
5
QVT Financial
New York
$12.9M

Top Sellers

1
First Eagle Investment Management
1
First Eagle Investment Management
New York
$0
2
Franklin Resources
2
Franklin Resources
California
$7.53M
3
SFM
3
Sphera Funds Management
Israel
$822K
4
Allianz Asset Management
4
Allianz Asset Management
Germany
$0
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$0
Name Market Value Shares Shares
Change 		Shares
Change %
PCM
101
Prelude Capital Management
New York
– – – –
US Bancorp
102
US Bancorp
Minnesota
$0 16 – –
1832 Asset Management
103
1832 Asset Management
Ontario, Canada
$0 19 +19 New
1 2 3 4
5